Stock Rich List
Nasdaq: HALO

Halozyme Therapeutics insiders

The officers, directors and 10% owners of Halozyme Therapeutics, Inc. who hold the most stock, valued at the live HALO price.

$93.04
HALO today −$2.8M (−2.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their HALO stock
$115M
Market value
$10.61B
Held by ranked insiders
1.08%

Insiders by value of HALO holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Helen TorleyPRESIDENT AND CEO767,780$71.4M0.67%1959th
2Connie MatsuiDirector183,035$17.0M0.16%5831st
3Michael J. LaBarreSVP, CHIEF TECHNICAL OFFICER173,756$16.2M0.15%6059th
4Jean-Pierre BizzariDirector66,815$6.2M<0.1%12191st
5Jeffrey William HendersonDirector36,572$3.4M<0.1%10173rd
6David A. RamsayEVP, PRESIDENT, DRUG DELIVERY4,592$427K<0.1%6943rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Halozyme Therapeutics; see each profile for the filing.